Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Herpesvirus 8, Human | 39 | 2024 | 255 | 10.640 |
Why?
|
Antigens, Viral | 37 | 2024 | 983 | 6.710 |
Why?
|
Sarcoma, Kaposi | 15 | 2024 | 373 | 4.090 |
Why?
|
Nuclear Proteins | 34 | 2024 | 5746 | 3.660 |
Why?
|
Virus Latency | 17 | 2024 | 364 | 3.420 |
Why?
|
Plasmids | 17 | 2020 | 2275 | 3.340 |
Why?
|
DNA, Viral | 25 | 2021 | 2171 | 2.530 |
Why?
|
Terminal Repeat Sequences | 13 | 2019 | 69 | 2.480 |
Why?
|
DNA Replication | 13 | 2019 | 1377 | 1.620 |
Why?
|
Gene Expression Regulation, Viral | 6 | 2024 | 437 | 1.390 |
Why?
|
Rhadinovirus | 7 | 2018 | 37 | 1.190 |
Why?
|
Virus Replication | 11 | 2024 | 2452 | 1.180 |
Why?
|
Chromosomes | 7 | 2019 | 573 | 1.030 |
Why?
|
Nucleosomes | 4 | 2014 | 480 | 0.830 |
Why?
|
Genome, Viral | 7 | 2020 | 663 | 0.770 |
Why?
|
Herpesviridae Infections | 6 | 2019 | 270 | 0.720 |
Why?
|
Herpesvirus 4, Human | 11 | 2016 | 1065 | 0.690 |
Why?
|
Mitosis | 8 | 2019 | 1190 | 0.680 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2021 | 298 | 0.660 |
Why?
|
Ganciclovir | 1 | 2019 | 253 | 0.650 |
Why?
|
Viral Matrix Proteins | 8 | 1999 | 197 | 0.630 |
Why?
|
Germinal Center | 2 | 2017 | 379 | 0.600 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2021 | 674 | 0.580 |
Why?
|
Chromosomes, Human | 4 | 2011 | 442 | 0.580 |
Why?
|
Opportunistic Infections | 1 | 2019 | 376 | 0.550 |
Why?
|
beta-Lactams | 2 | 2009 | 151 | 0.520 |
Why?
|
Cell Transformation, Viral | 9 | 2020 | 526 | 0.520 |
Why?
|
Replication Protein C | 1 | 2014 | 22 | 0.490 |
Why?
|
B-Lymphocytes | 12 | 2023 | 4671 | 0.480 |
Why?
|
Antiviral Agents | 2 | 2019 | 3012 | 0.480 |
Why?
|
Cytomegalovirus Infections | 1 | 2019 | 823 | 0.430 |
Why?
|
Host-Pathogen Interactions | 6 | 2021 | 1442 | 0.390 |
Why?
|
Gastrointestinal Diseases | 1 | 2019 | 1169 | 0.380 |
Why?
|
Herpesvirus 6, Human | 1 | 2011 | 95 | 0.370 |
Why?
|
Viral Proteins | 7 | 2019 | 1800 | 0.360 |
Why?
|
Tumor Virus Infections | 3 | 2020 | 437 | 0.330 |
Why?
|
Protein Binding | 12 | 2021 | 9278 | 0.330 |
Why?
|
Lymphoma, Primary Effusion | 2 | 2020 | 17 | 0.330 |
Why?
|
Cell Line, Tumor | 11 | 2021 | 16657 | 0.310 |
Why?
|
Virulence Factors | 1 | 2011 | 502 | 0.310 |
Why?
|
Cell Line | 14 | 2019 | 15631 | 0.280 |
Why?
|
Proliferating Cell Nuclear Antigen | 2 | 2019 | 280 | 0.270 |
Why?
|
Centromere | 1 | 2006 | 214 | 0.260 |
Why?
|
Histones | 5 | 2020 | 2552 | 0.250 |
Why?
|
Anti-Bacterial Agents | 4 | 2009 | 7222 | 0.250 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2019 | 2389 | 0.240 |
Why?
|
Crystallography, X-Ray | 3 | 2021 | 1970 | 0.240 |
Why?
|
Protein Conformation | 4 | 2021 | 3959 | 0.230 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2021 | 2855 | 0.230 |
Why?
|
Gene Knockdown Techniques | 2 | 2021 | 1618 | 0.230 |
Why?
|
Antigens, Nuclear | 2 | 2019 | 185 | 0.220 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2021 | 2800 | 0.210 |
Why?
|
Enhancer Elements, Genetic | 2 | 2020 | 1328 | 0.200 |
Why?
|
Proto-Oncogene Proteins c-myc | 3 | 2020 | 982 | 0.200 |
Why?
|
S-Phase Kinase-Associated Proteins | 1 | 2021 | 90 | 0.200 |
Why?
|
DNA | 2 | 2024 | 7199 | 0.200 |
Why?
|
Cell Nucleus | 4 | 2019 | 2898 | 0.190 |
Why?
|
Binding Sites | 8 | 2018 | 6025 | 0.180 |
Why?
|
DNA-Binding Proteins | 5 | 2018 | 9521 | 0.180 |
Why?
|
Humans | 60 | 2024 | 746044 | 0.180 |
Why?
|
Electrophoretic Mobility Shift Assay | 2 | 2013 | 295 | 0.180 |
Why?
|
Viral Load | 3 | 2019 | 3297 | 0.180 |
Why?
|
Molecular Sequence Data | 11 | 2013 | 17675 | 0.170 |
Why?
|
Biosensing Techniques | 2 | 2016 | 661 | 0.170 |
Why?
|
Bacterial Infections | 3 | 2009 | 1395 | 0.170 |
Why?
|
NF-kappa B | 6 | 1999 | 2461 | 0.170 |
Why?
|
Pulmonary Fibrosis | 1 | 2023 | 503 | 0.160 |
Why?
|
Lymphoma, B-Cell | 2 | 2016 | 925 | 0.150 |
Why?
|
Protein Folding | 3 | 2013 | 845 | 0.150 |
Why?
|
Adenosine Kinase | 1 | 2017 | 12 | 0.150 |
Why?
|
Purine Nucleosides | 1 | 2017 | 30 | 0.150 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2023 | 478 | 0.150 |
Why?
|
Tumor Cells, Cultured | 6 | 2013 | 6137 | 0.150 |
Why?
|
Cell Cycle Proteins | 4 | 2019 | 3408 | 0.140 |
Why?
|
Promoter Regions, Genetic | 3 | 2020 | 5760 | 0.140 |
Why?
|
Mutation | 8 | 2015 | 29614 | 0.140 |
Why?
|
Virus Diseases | 1 | 2023 | 722 | 0.140 |
Why?
|
Recombination, Genetic | 5 | 2013 | 1532 | 0.140 |
Why?
|
Lymphoma | 3 | 2002 | 1872 | 0.140 |
Why?
|
Amino Acid Sequence | 8 | 2018 | 13494 | 0.140 |
Why?
|
Protein Structure, Tertiary | 6 | 2015 | 3784 | 0.140 |
Why?
|
Base Sequence | 7 | 2011 | 12447 | 0.140 |
Why?
|
HEK293 Cells | 3 | 2020 | 4178 | 0.130 |
Why?
|
DNA-Directed DNA Polymerase | 2 | 2019 | 482 | 0.130 |
Why?
|
Clarithromycin | 1 | 1995 | 85 | 0.130 |
Why?
|
Microscopy, Fluorescence | 2 | 2013 | 2658 | 0.120 |
Why?
|
Static Electricity | 1 | 2015 | 264 | 0.120 |
Why?
|
Pulmonary Embolism | 2 | 2023 | 2499 | 0.120 |
Why?
|
DNA Repair | 1 | 2024 | 2016 | 0.120 |
Why?
|
Electricity | 1 | 2015 | 184 | 0.120 |
Why?
|
Dimerization | 2 | 2006 | 886 | 0.120 |
Why?
|
Azithromycin | 1 | 1995 | 196 | 0.120 |
Why?
|
Monocytes | 1 | 2023 | 2544 | 0.120 |
Why?
|
Fluorescence Polarization | 1 | 2014 | 133 | 0.110 |
Why?
|
Chromatin | 3 | 2013 | 2896 | 0.110 |
Why?
|
Gene Expression | 2 | 2024 | 7580 | 0.110 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2015 | 216 | 0.110 |
Why?
|
Anti-Infective Agents, Local | 1 | 1995 | 244 | 0.110 |
Why?
|
Lymphoproliferative Disorders | 1 | 2016 | 532 | 0.110 |
Why?
|
Animals | 19 | 2021 | 166331 | 0.110 |
Why?
|
Gram-Negative Aerobic Bacteria | 1 | 1992 | 8 | 0.110 |
Why?
|
Half-Life | 1 | 2013 | 647 | 0.100 |
Why?
|
Proteins | 6 | 1999 | 6000 | 0.100 |
Why?
|
Gene Regulatory Networks | 1 | 2020 | 1695 | 0.100 |
Why?
|
Fever | 1 | 2019 | 1604 | 0.100 |
Why?
|
Chickens | 1 | 2014 | 853 | 0.100 |
Why?
|
Glutathione Transferase | 1 | 2014 | 562 | 0.100 |
Why?
|
Amino Acid Substitution | 2 | 2007 | 1743 | 0.100 |
Why?
|
Spectrometry, Fluorescence | 1 | 2014 | 683 | 0.100 |
Why?
|
Headache | 1 | 2019 | 1223 | 0.100 |
Why?
|
DNA Primers | 3 | 2013 | 2810 | 0.090 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2015 | 429 | 0.090 |
Why?
|
Chromosome Segregation | 1 | 2011 | 234 | 0.090 |
Why?
|
Cell Survival | 3 | 2017 | 5761 | 0.090 |
Why?
|
Nanostructures | 1 | 2015 | 539 | 0.090 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 3782 | 0.090 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 1992 | 235 | 0.090 |
Why?
|
Proteomics | 1 | 2023 | 3709 | 0.090 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2016 | 1853 | 0.090 |
Why?
|
Cell Division | 4 | 2011 | 4438 | 0.080 |
Why?
|
Thallium Radioisotopes | 1 | 1989 | 138 | 0.080 |
Why?
|
Cell Culture Techniques | 1 | 2016 | 1656 | 0.080 |
Why?
|
Mice | 10 | 2021 | 80087 | 0.080 |
Why?
|
Models, Molecular | 3 | 2015 | 5379 | 0.080 |
Why?
|
TNF Receptor-Associated Factor 2 | 6 | 1999 | 57 | 0.080 |
Why?
|
Flow Cytometry | 3 | 2015 | 5835 | 0.080 |
Why?
|
HeLa Cells | 2 | 2014 | 3077 | 0.080 |
Why?
|
Ubiquitination | 1 | 2013 | 994 | 0.080 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2021 | 8355 | 0.080 |
Why?
|
Genomic Instability | 1 | 2013 | 687 | 0.080 |
Why?
|
Drug Design | 1 | 2014 | 1055 | 0.080 |
Why?
|
Macrophages | 1 | 2023 | 5652 | 0.080 |
Why?
|
Antigens | 1 | 2014 | 1438 | 0.080 |
Why?
|
High-Throughput Screening Assays | 1 | 2014 | 925 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2020 | 3609 | 0.070 |
Why?
|
Catheterization, Central Venous | 1 | 1992 | 511 | 0.070 |
Why?
|
COS Cells | 2 | 2007 | 1130 | 0.070 |
Why?
|
Genome, Human | 1 | 2020 | 4356 | 0.070 |
Why?
|
Mammalian orthoreovirus 3 | 1 | 1986 | 45 | 0.070 |
Why?
|
Immunocompromised Host | 1 | 1992 | 846 | 0.070 |
Why?
|
Hemagglutinins, Viral | 1 | 1986 | 66 | 0.070 |
Why?
|
Alanine | 1 | 2009 | 581 | 0.070 |
Why?
|
Polymerase Chain Reaction | 3 | 2011 | 6058 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4576 | 0.070 |
Why?
|
Fluorescent Dyes | 1 | 2014 | 1892 | 0.070 |
Why?
|
Reoviridae | 1 | 1986 | 161 | 0.070 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 1996 | 2881 | 0.070 |
Why?
|
Blotting, Western | 1 | 2013 | 5048 | 0.070 |
Why?
|
MicroRNAs | 1 | 2021 | 3742 | 0.060 |
Why?
|
Chromosomes, Mammalian | 1 | 2006 | 146 | 0.060 |
Why?
|
Cell Proliferation | 2 | 2020 | 10300 | 0.060 |
Why?
|
Amoxicillin-Potassium Clavulanate Combination | 1 | 2004 | 34 | 0.060 |
Why?
|
Erythrocytes | 1 | 2014 | 2397 | 0.060 |
Why?
|
Immunoprecipitation | 1 | 2007 | 874 | 0.060 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2006 | 426 | 0.060 |
Why?
|
Genomics | 1 | 2020 | 5694 | 0.060 |
Why?
|
Lactams | 1 | 2004 | 155 | 0.060 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2007 | 1689 | 0.060 |
Why?
|
Cephalosporins | 1 | 2004 | 202 | 0.060 |
Why?
|
Genes, Viral | 2 | 1999 | 653 | 0.050 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2007 | 628 | 0.050 |
Why?
|
Lymphocyte Activation | 1 | 1993 | 5413 | 0.050 |
Why?
|
Base Composition | 1 | 2002 | 289 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2015 | 4296 | 0.050 |
Why?
|
Xenopus laevis | 1 | 2006 | 962 | 0.050 |
Why?
|
Exercise Test | 1 | 1989 | 2082 | 0.050 |
Why?
|
Lymphocytes | 2 | 1999 | 2589 | 0.050 |
Why?
|
TNF Receptor-Associated Factor 1 | 5 | 1999 | 50 | 0.050 |
Why?
|
TNF Receptor-Associated Factor 3 | 5 | 1999 | 40 | 0.050 |
Why?
|
Immunity, Cellular | 1 | 2007 | 1548 | 0.050 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2002 | 782 | 0.050 |
Why?
|
Precipitin Tests | 1 | 2001 | 819 | 0.040 |
Why?
|
Aminoglycosides | 1 | 2000 | 161 | 0.040 |
Why?
|
Cosmids | 1 | 1999 | 106 | 0.040 |
Why?
|
Herpesvirus 2, Saimiriine | 1 | 1999 | 61 | 0.040 |
Why?
|
Interferon Regulatory Factors | 1 | 2020 | 256 | 0.040 |
Why?
|
DNA, Complementary | 1 | 2002 | 1993 | 0.040 |
Why?
|
Child | 3 | 2023 | 78456 | 0.040 |
Why?
|
Recombinant Fusion Proteins | 2 | 2006 | 3722 | 0.040 |
Why?
|
Bacteria | 1 | 2009 | 2133 | 0.040 |
Why?
|
Interphase | 1 | 1999 | 228 | 0.040 |
Why?
|
Nucleic Acid Conformation | 2 | 2015 | 889 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2013 | 12741 | 0.040 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2006 | 1571 | 0.040 |
Why?
|
Structure-Activity Relationship | 1 | 2004 | 3077 | 0.040 |
Why?
|
Virus Integration | 1 | 2020 | 297 | 0.040 |
Why?
|
RNA Splicing | 1 | 2002 | 906 | 0.040 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 1999 | 445 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2019 | 63661 | 0.040 |
Why?
|
Gene Knockout Techniques | 1 | 2020 | 789 | 0.040 |
Why?
|
Acetylation | 1 | 2020 | 1046 | 0.040 |
Why?
|
HIV-1 | 1 | 2015 | 6870 | 0.040 |
Why?
|
Oncogene Proteins, Viral | 1 | 1999 | 342 | 0.040 |
Why?
|
Phenotype | 2 | 2009 | 16245 | 0.040 |
Why?
|
Fibroblasts | 2 | 1999 | 4036 | 0.040 |
Why?
|
3T3 Cells | 1 | 2018 | 1083 | 0.040 |
Why?
|
Inhibitory Concentration 50 | 1 | 2017 | 458 | 0.030 |
Why?
|
Transfection | 3 | 1999 | 5786 | 0.030 |
Why?
|
Pyoderma | 1 | 1995 | 7 | 0.030 |
Why?
|
Peptides | 1 | 2007 | 4313 | 0.030 |
Why?
|
Mice, Nude | 1 | 2021 | 3581 | 0.030 |
Why?
|
Binding, Competitive | 1 | 1996 | 1138 | 0.030 |
Why?
|
Spleen | 2 | 2015 | 2272 | 0.030 |
Why?
|
Pulmonary Artery | 1 | 2023 | 1919 | 0.030 |
Why?
|
Virus Activation | 1 | 2016 | 316 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 1997 | 576 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 1999 | 1248 | 0.030 |
Why?
|
Limit of Detection | 1 | 2015 | 260 | 0.030 |
Why?
|
DNA, Recombinant | 1 | 1995 | 453 | 0.030 |
Why?
|
Mutant Proteins | 1 | 2016 | 491 | 0.030 |
Why?
|
Coronary Disease | 1 | 1989 | 5924 | 0.030 |
Why?
|
Osmolar Concentration | 1 | 2015 | 664 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2017 | 13538 | 0.030 |
Why?
|
Thermodynamics | 1 | 2015 | 593 | 0.030 |
Why?
|
Endonucleases | 1 | 2016 | 369 | 0.030 |
Why?
|
Antigens, Ly | 1 | 2015 | 290 | 0.030 |
Why?
|
Cytoplasm | 2 | 1996 | 1520 | 0.030 |
Why?
|
Enzyme Activation | 1 | 1999 | 3601 | 0.030 |
Why?
|
Wound Infection | 1 | 1995 | 242 | 0.030 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 1 | 2013 | 143 | 0.030 |
Why?
|
Blotting, Southern | 1 | 1993 | 781 | 0.030 |
Why?
|
Microscopy, Confocal | 1 | 1999 | 1972 | 0.030 |
Why?
|
Codon | 1 | 1995 | 602 | 0.030 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2013 | 280 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2017 | 1809 | 0.030 |
Why?
|
Phylogeny | 1 | 2020 | 2736 | 0.030 |
Why?
|
Bromodeoxyuridine | 1 | 2013 | 310 | 0.030 |
Why?
|
Adult | 4 | 2019 | 214958 | 0.030 |
Why?
|
Drug Resistance, Microbial | 1 | 1995 | 851 | 0.030 |
Why?
|
Cell Line, Transformed | 1 | 1993 | 876 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2000 | 4858 | 0.030 |
Why?
|
Mice, SCID | 1 | 2017 | 2620 | 0.020 |
Why?
|
F-Box Proteins | 1 | 2013 | 200 | 0.020 |
Why?
|
In Situ Nick-End Labeling | 1 | 2013 | 614 | 0.020 |
Why?
|
Reference Standards | 1 | 2015 | 1001 | 0.020 |
Why?
|
Protein Stability | 1 | 2013 | 563 | 0.020 |
Why?
|
Female | 6 | 2023 | 382109 | 0.020 |
Why?
|
Oligonucleotides, Antisense | 1 | 1993 | 448 | 0.020 |
Why?
|
Neoplasms | 1 | 2020 | 21688 | 0.020 |
Why?
|
HIV Infections | 2 | 2015 | 16936 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2015 | 2503 | 0.020 |
Why?
|
Protein Multimerization | 1 | 2015 | 965 | 0.020 |
Why?
|
Acne Vulgaris | 1 | 1995 | 343 | 0.020 |
Why?
|
Protein Structure, Secondary | 1 | 1993 | 1238 | 0.020 |
Why?
|
Immunoblotting | 1 | 1993 | 1649 | 0.020 |
Why?
|
Open Reading Frames | 1 | 1993 | 809 | 0.020 |
Why?
|
Catheterization | 1 | 1995 | 1425 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2013 | 866 | 0.020 |
Why?
|
Th1 Cells | 1 | 2015 | 999 | 0.020 |
Why?
|
Microfluidics | 1 | 2015 | 662 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2020 | 21529 | 0.020 |
Why?
|
Up-Regulation | 1 | 2019 | 4114 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2007 | 10018 | 0.020 |
Why?
|
Environment | 1 | 2015 | 1111 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2015 | 14211 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2017 | 3526 | 0.020 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2015 | 597 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2002 | 7571 | 0.020 |
Why?
|
Temperature | 1 | 2015 | 2194 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2016 | 4119 | 0.020 |
Why?
|
Respiratory Tract Infections | 1 | 1995 | 985 | 0.020 |
Why?
|
Computational Biology | 1 | 2020 | 3484 | 0.020 |
Why?
|
Recombinant Proteins | 2 | 1996 | 6508 | 0.020 |
Why?
|
Interleukin-6 | 1 | 1997 | 3153 | 0.020 |
Why?
|
Equipment Design | 1 | 2015 | 3509 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2016 | 2540 | 0.020 |
Why?
|
Callithrix | 2 | 1999 | 93 | 0.020 |
Why?
|
Reoviridae Infections | 1 | 1986 | 58 | 0.020 |
Why?
|
Point-of-Care Systems | 1 | 2015 | 1177 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2015 | 3133 | 0.020 |
Why?
|
Cardiomegaly | 1 | 1989 | 593 | 0.020 |
Why?
|
Epitopes | 2 | 2007 | 2505 | 0.020 |
Why?
|
Incidence | 1 | 2023 | 20812 | 0.020 |
Why?
|
Genotype | 1 | 2020 | 12773 | 0.020 |
Why?
|
Macromolecular Substances | 1 | 2007 | 1439 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 1989 | 1978 | 0.020 |
Why?
|
Heart Transplantation | 1 | 1998 | 3032 | 0.020 |
Why?
|
Surface Properties | 1 | 2007 | 1154 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14537 | 0.020 |
Why?
|
Neutralization Tests | 1 | 1986 | 730 | 0.010 |
Why?
|
Lung | 1 | 2023 | 9842 | 0.010 |
Why?
|
Burns | 1 | 1995 | 1846 | 0.010 |
Why?
|
Cell Membrane | 1 | 1993 | 3687 | 0.010 |
Why?
|
Cells, Cultured | 1 | 1999 | 18891 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2015 | 4335 | 0.010 |
Why?
|
Hospitalization | 1 | 2023 | 10329 | 0.010 |
Why?
|
Transcription Factors | 2 | 2016 | 12039 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2015 | 9441 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2017 | 5159 | 0.010 |
Why?
|
Immunophenotyping | 1 | 2007 | 1853 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2015 | 4515 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2015 | 3011 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2020 | 15366 | 0.010 |
Why?
|
Immunologic Memory | 1 | 2007 | 1331 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2013 | 4926 | 0.010 |
Why?
|
Brain | 1 | 1986 | 26596 | 0.010 |
Why?
|
Aotidae | 1 | 1999 | 59 | 0.010 |
Why?
|
Apoptosis | 1 | 2015 | 9421 | 0.010 |
Why?
|
Genome | 1 | 2006 | 1744 | 0.010 |
Why?
|
Infant | 1 | 2000 | 35444 | 0.010 |
Why?
|
Male | 5 | 2019 | 351093 | 0.010 |
Why?
|
Pleural Effusion, Malignant | 1 | 1998 | 99 | 0.010 |
Why?
|
HIV Seronegativity | 1 | 1998 | 208 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2015 | 11384 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2015 | 19804 | 0.010 |
Why?
|
Intestines | 1 | 1986 | 1892 | 0.010 |
Why?
|
Heart Ventricles | 1 | 1989 | 3772 | 0.010 |
Why?
|
United States | 1 | 2004 | 70383 | 0.010 |
Why?
|
Mutagenesis | 1 | 1999 | 1223 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2023 | 78297 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 1989 | 12839 | 0.010 |
Why?
|
Epithelium | 1 | 1997 | 1610 | 0.010 |
Why?
|
Sequence Deletion | 1 | 1997 | 1490 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1996 | 2766 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 1996 | 1752 | 0.010 |
Why?
|
Child, Preschool | 1 | 1992 | 41376 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 1996 | 2106 | 0.010 |
Why?
|
Kinetics | 1 | 1996 | 6352 | 0.010 |
Why?
|
Time Factors | 1 | 1986 | 39587 | 0.000 |
Why?
|
Urinary Bladder Neoplasms | 1 | 1997 | 2244 | 0.000 |
Why?
|
Hematopoietic Stem Cells | 1 | 1997 | 3345 | 0.000 |
Why?
|
Rats | 1 | 1999 | 23680 | 0.000 |
Why?
|
Ovarian Neoplasms | 1 | 1997 | 4845 | 0.000 |
Why?
|
Gene Expression Regulation | 1 | 1996 | 11839 | 0.000 |
Why?
|
Aged | 1 | 1989 | 164236 | 0.000 |
Why?
|
Middle Aged | 1 | 1998 | 214412 | 0.000 |
Why?
|